Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ramani R. Ranatunge"'
Autor:
A. Mark Trocha, David S. Garvey, Michael E. Augustyniak, Stewart K. Richardson, Mathew J. Shumway, David R. Janero, Delano V. Young, L. Gordon Letts, James L. Ellis, Ramani R. Ranatunge, Irina S. Zemtseva, Vijay Dhawan
Publikováno v:
Bioorganic & Medicinal Chemistry. 14:2589-2599
A series of glycolamide naproxen prodrugs containing a nitrate group as a nitric oxide (NO) donor moiety has been synthesized. These compounds were evaluated for their anti-inflammatory activity, naproxen release, and gastric tolerance. Compounds 4a,
Autor:
David R. Janero, Ramani R. Ranatunge, Matthew J. Shumway, Delano V. Young, James L. Ellis, Joseph D. Schroeder, S. William Tam, David S. Garvey, A. Mark Trocha, L. Gordon Letts, Madhavi G. Murty, Michael E. Augustyniak, Richard A. Earl, Upul K. Bandarage, Allison M. Martino, Stewart K. Richardson
Publikováno v:
Journal of Medicinal Chemistry. 47:2180-2193
The synthesis of a series of novel pyrazoles containing a nitrate (ONO(2)) moiety as a nitric oxide (NO)-donor functionality is reported. Their COX-1 and COX-2 inhibitory activities in human whole blood are profiled. Our data demonstrate that pyrazol
Autor:
L. Gordon Letts, Delano V. Young, Madhavi G. Murty, Stewart K. Richardson, Ramani R. Ranatunge, Allison M. Martino, David R. Janero, David S. Garvey, Irina S. Zemetseva
Publikováno v:
Bioorganic & Medicinal Chemistry. 12:1357-1366
Novel series of pyrazolo[5,1- b ]1,3-oxazolidines, pyrazolo[5,1- b ]1,3-oxazines and imidazolidino[1,2- d ]pyrazoles were synthesized. These compounds were evaluated in vitro for their ability to inhibit cyclooxygenase-1 (COX-1) and cyclooxygenase-2
Publikováno v:
Organometallics. 13:500-510
Autor:
Noel W. Duffy, Brian H. Robinson, P. Ramani R. Ranatunge-Bandarage, Jim Simpson, S. Margaret Johnston
Publikováno v:
Organometallics. 13:511-521
Autor:
Ramani R. Ranatunge, et al. et al.
Publikováno v:
ChemInform. 36